Andrea Biondi joins The Lancet Haematology to discuss his work on imatinib as a treatment for paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia.

Andrea Biondi joins The Lancet Haematology to discuss his work on imatinib as a treatment for paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia.

Andrea Biondi joins&nbsp;The Lancet Haematology to discuss his work on imatinib as a treatment for&nbsp;paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia.

Imatinib for paediatric leukaemia

Lan-Lan Smith, Editor-in-Chief of The Lancet Haematology, and the journal’s authors explore their research and its impact on people’s health, health care, and health policy in this regular podcast.

Share Imatinib for paediatric leukaemia

Sign up to save your podcasts

Imatinib for paediatric leukaemia

Imatinib for paediatric leukaemia